Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Tsourdi, E., Zillikens, M. C., Meier, C., Body, J. J., Gonzalez Rodriguez, E., Anastasilakis, A. D., Abrahamsen, B., Mccloskey, E., Hofbauer, L. C., Guañabens, N., Obermayer-Pietsch, B., Ralston, S. H., Eastell, R., Pepe, J., Palermo, A. & Langdahl, B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS. Journal of Clinical Endocrinology and Metabolism, 106(1), 264-281. https://doi.org/10.1210/clinem/dgaa756

Tveden-Nyborg, P., Bergmann, T. K., Jessen, N., Simonsen, U. & Lykkesfeldt, J. (2021). BCPT policy for experimental and clinical studies. Basic and Clinical Pharmacology and Toxicology, 128(1), 4-8. https://doi.org/10.1111/bcpt.13492

Vajavaara, H., Mortensen, J. B., Leivonen, S.-K., Hansen, I. M., Ludvigsen, M., Holte, H., Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021). Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers, 13(3), Article 398. https://doi.org/10.3390/cancers13030398

Valentin, G., Friis, K., Nielsen, C. P., Larsen, F. B. & Langdahl, B. L. (2021). Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study. Osteoporosis International, 32(1), 63-73. https://doi.org/10.1007/s00198-020-05540-8

Valentin, G., Ravn, M. B., Jensen, E. K., Friis, K., Bhimjiyani, A., Ben-Shlomo, Y., Hartley, A., Nielsen, C. P., Langdahl, B. & Gregson, C. L. (2021). Socio-economic inequalities in fragility fracture incidence: A systematic review and meta-analysis of 61 observational studies. Osteoporosis International, 32(12), 2433-2448. https://doi.org/10.1007/s00198-021-06038-7

Vestergaard, E. T., Zubanovic, N. B., Rittig, N., Moller, N., Kuhre, R. E., Holst, J. J., Rehfeld, J. F. & Thomsen, H. H. (2021). Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men. Diabetes, Obesity and Metabolism, 23(8), 1834-1842. https://doi.org/10.1111/dom.14402

Viggers, R., Al-Mashhadi, Z., Starup-Linde, J. & Vestergaard, P. (2021). Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study. Frontiers in Endocrinology, 12, Article 771426. https://doi.org/10.3389/fendo.2021.771426

Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, P. & Jørgensen, M. E. (2021). A validated prediction model for end-stage kidney disease in type 1 diabetes. Diabetes Care, 44(4), 901-907. https://doi.org/10.2337/dc20-2586

Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, P. & Jørgensen, M. E. (2021). Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907. Diabetes Care, 44(6), e140-e141. https://doi.org/10.2337/dci21-0010

Viuff, M. H., Stochholm, K., Lin, A., Berglund, A., Juul, S. & Gravholt, C. H. (2021). Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy. European Journal of Endocrinology, 184(1), 79-88. https://doi.org/10.1530/EJE-20-0702

Displaying results 1571 to 1580 out of 4099

158

Revised 11.09.2025

-

Department of Clinical Medicine